This study describes the histochemical localisation of monoamine oxidase (MAO) in marmoset brain. No MAO A staining was observed but MAO B was found in many areas, with medium intensity of staining in the substantia nigra, and high intensity staining in the striatum and nucleus accumbens, among other regions. The high activity in the nigrostriatal tract, compared with the rat, may partially explain the greater sensitivity of the marmoset to MPTP toxicity. As in the rat, high activity was present in the raphe nuclei. However, unlike the rat, no enrichment of MAO B was observed in blood vessels or ventricular linings
The meperidine analogue derivative 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induces nigro...
<p>MPTP administration resulted in an asymmetric parkinsonism in NHP presenting a more severe dopami...
In this study, we evaluated the in vivo characteristics of a new monoamine oxidase type B (MAO-B) ra...
This study describes the histochemical localisation of monoamine oxidase (MAO) in marmoset brain. No...
1-Methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) is a new neurotoxin that caused degeneration of ...
A comparison of the MAO activity in the liver, kidney and intestine of the rat and monkey has been m...
The MPTP-treated common marmoset monkey is a valid Parkinson\u27s disease model. By using this model...
In the last decade, considerable interest has been focused on the role of biogenic amines and their ...
We have recently reported that a reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine...
<p>A dopamine transporter ligand, [<sup>11</sup>C]PE2I, was intravenously administered to marmosets....
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), or 0.9% saline, was administered to a group of ...
Specific binding of 3H-MPTP to brain homogenates is displaced predominantly by MAO-A inhibitor clorg...
The distribution and density of 3H-MPP+ binding sites were studied by in vitro quantitative autoradi...
MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), a selective nigrostriatal neurotoxin, is bioact...
AbstractThe neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was oxidized to dihydropy...
The meperidine analogue derivative 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induces nigro...
<p>MPTP administration resulted in an asymmetric parkinsonism in NHP presenting a more severe dopami...
In this study, we evaluated the in vivo characteristics of a new monoamine oxidase type B (MAO-B) ra...
This study describes the histochemical localisation of monoamine oxidase (MAO) in marmoset brain. No...
1-Methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) is a new neurotoxin that caused degeneration of ...
A comparison of the MAO activity in the liver, kidney and intestine of the rat and monkey has been m...
The MPTP-treated common marmoset monkey is a valid Parkinson\u27s disease model. By using this model...
In the last decade, considerable interest has been focused on the role of biogenic amines and their ...
We have recently reported that a reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine...
<p>A dopamine transporter ligand, [<sup>11</sup>C]PE2I, was intravenously administered to marmosets....
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), or 0.9% saline, was administered to a group of ...
Specific binding of 3H-MPTP to brain homogenates is displaced predominantly by MAO-A inhibitor clorg...
The distribution and density of 3H-MPP+ binding sites were studied by in vitro quantitative autoradi...
MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), a selective nigrostriatal neurotoxin, is bioact...
AbstractThe neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was oxidized to dihydropy...
The meperidine analogue derivative 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induces nigro...
<p>MPTP administration resulted in an asymmetric parkinsonism in NHP presenting a more severe dopami...
In this study, we evaluated the in vivo characteristics of a new monoamine oxidase type B (MAO-B) ra...